Xenometrix PAN I Cytotoxicity assay kit

Wednesday, 21 July, 2010 | Supplied by: Haematex Research Pty Ltd


In order to determine which novel compounds are warranted for further development, early detection of unwanted cytotoxic effects is vital.

Cytotoxic evaluation on cell lines has well established and widely accepted methods. In use are several different cellular targets using various read-outs and different exposure protocols. Toxicity testing at early stages of new product development should have high sensitivity, ie, effectively toxic substances should have a high probability of being identified. Tests should be reasonably simple, reproducible and cost effective.

The PAN I Cytotoxicity assay kit by Xenometrix allows applying four commonly used cytotoxicity assays sequentially on one cellular sample. It combines assays for extracellular lactate dehydrogenase (LDHe) to measure membrane integrity, the XTT tetrazolium salt to evaluate mitochondrial activity, neutral red (NR) for the evaluation of lysosomal activity and the sulforhodamine stain (SRB) for total protein content. This allows an investigator to identify the site of any cytotoxic damage.

This valuable information on cellular target structures can help decide which products are more suitable for further development and therefore where to focus investment resources.

Online: www.haematex.com
Phone: 02 9482 2288
Related Products

Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit

The kit includes a comprehensive set of optimised screening reagents and conditions that...

Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit

The kit enables simultaneous detection, discrimination and absolute quantification of seven known...

AdipoGen Life Sciences InVivoKines recombinant fusion proteins

InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd